Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.338
-0.017 (-4.66%)
At close: Jan 21, 2025, 4:00 PM
0.328
-0.009 (-2.76%)
After-hours: Jan 21, 2025, 7:47 PM EST
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.36 million as of January 21, 2025. Its market cap has increased by 9.54% in one year.
Market Cap
3.36M
Enterprise Value
244.73K
1-Year Change
9.54%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $792.87M to $3.36M, a decrease of -99.58%. That is a compound annual growth rate of -74.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.52M | -1.23% |
| Dec 31, 2024 | 3.56M | 18.11% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -96.32% |
| Dec 31, 2020 | 792.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |